NORTHERN CALIFORNIA CANCER PROGRAM CCOP RESEARCH BASE

北加州癌症计划 CCOP 研究基地

• 批准号: 3558156
• 负责人: Theodore Phillips
• 金额: $ 6.42万
• 依托单位: CANCER PREVENTION INSTIT OF CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-30 至 1990-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3558156
• 关键词: Hodgkin's disease; antineoplastics; brain neoplasms; cancer information system; cancer registry /resource; cancer rehabilitation /care; cancer risk; community health services; continuing education; eye neoplasms; gastrointestinal neoplasms; head /neck neoplasm; health science research analysis /evaluation; human subject; metastasis; neoplasm /cancer education; neoplasm /cancer radiation therapy; neoplasm /cancer therapy; patient /disease registry; patient care planning; pharmacy administration; reproductive system neoplasm; urinary tract neoplasms

The Northern California Cancer Program (NCCP) is the NCI- designated consortium cancer center for the Northern California and Northwestern Nevada regions. The Northern California Oncology Group (NCOG) is an integral component of NCCP, deriving its personnel and resources form three of NCCP's five major scientific programs (clinical research, biostatistics and cancer control). NCOG has established an excellent track record over more than a decade of conducting innovative cancer clinical trials, with effective cooperation between academic institutions and community hospitals. The NCCP proposes to serve as a cancer treatment and cancer control research base for the four affiliated CCOP institutions in Northern California and Northwestern Nevada and as a cancer control research base for other non-CCOP institutions in this same region. Through the NCOG clinical trials program, the NCCP will provide CCOP institutions with access to innovative Phase II and III treatment protocols for patients with head and neck cancer, genitourinary cancer, gastrointestinal cancer, brain tumors, ocular melanoma, Hodgkin's disease and other selected neoplasms. Through this same clinical trials program, the NCCP will provide both CCOP and non-CCOP institutions with access to innovative Phase II and III cancer control protocols designed to: a) improve the quality of life and to assess/reduce the incidence of secondary cancers in patients with selected primary neoplasms; or b) assess/reduce the risk of primary cancer among individuals at high risk for the development of malignancy.

北加州癌症计划 (NCCP) 是 NCI- 北加州指定联盟癌症中心 和内华达州西北部地区。 北加州 肿瘤学组 (NCOG) 是 NCCP 的组成部分， 其人员和资源来自 NCCP 五个部门中的三个 主要科学计划（临床研究、生物统计学和 癌症控制）。 NCOG 已建立了良好的记录 十多年来进行创新的癌症临床 学术机构之间有效合作进行试验 和社区医院。 NCCP 提议作为癌症治疗和癌症 CCOP下属四个机构的控制研究基地 北加州和内华达州西北部以及作为癌症 其他非CCOP机构在本领域的控制研究基地 同一地区。 通过 NCOG 临床试验计划， NCCP 将为 CCOP 机构提供获得创新成果的机会 针对头部和头部患者的 II 期和 III 期治疗方案 颈部癌、泌尿生殖系统癌、胃肠道癌、脑癌 肿瘤、眼部黑色素瘤、霍奇金病等精选 肿瘤。 通过同样的临床试验计划，NCCP 将为 CCOP 和非 CCOP 机构提供获得 创新的 II 期和 III 期癌症控制方案旨在： a) 改善生活质量并评估/减少发病率 患有选定原发性肿瘤的患者继发性癌症的发生； 或 b) 评估/降低个体患原发性癌症的风险 发生恶性肿瘤的风险很高。